Resistant to Tyrosine Kinase Inhibitor Therapy
1 clinical trials · Condition
◉ Watch Resistant to Tyrosine Kinase Inhibitor Therapy
| Record | Firm | Date |
|---|---|---|
| Phase I/II Study of Nilotinib/Ruxolitinb Therapy for TKI Resistant Ph-Leukemia (NCT01914484) | University Health Network, Toronto | 2013-08-01 |
Track Resistant to Tyrosine Kinase Inhibitor Therapy automatically
Every clearance here is in the API, with alerts when new ones post.